SEC 13F Intelligence

RUBIUS THERAPEUTICS INC

CUSIP 78116T103

Rubius Therapeutics Inc has 31 institutional holders in Filings Flow’s 13F database, together reporting 49.94M shares worth $7M as of Q4 2022.

Institutional Holders
31
Q4 2022
Reported Value
$7M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 37Q4 ’18Q1 ’19: 47Q1 ’19Q2 ’19: 49Q2 ’19Q3 ’19: 56Q3 ’19Q2 ’21: 95Q2 ’21Q4 ’21: 92Q4 ’21Q4 ’22: 31Q4 ’22filingsflow.com
Total reported value
Q4 ’18: $871MQ4 ’18Q1 ’19: $1.2BQ1 ’19Q2 ’19: $1.2BQ2 ’19Q3 ’19: $622MQ3 ’19Q2 ’21: $2.5BQ2 ’21Q4 ’21: $1.1BQ4 ’21Q4 ’22: $7MQ4 ’22filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
No holders match this filter.

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.